Highlights Novo Nordisk A/S Nyse

Equities

NVO

US6701002056

Market Closed - Nyse Other stock markets 21:00:02 10/05/2024 BST			5-day change	1st Jan Change
128.4 ^USD	-0.19%		+4.36%	+24.14%

05-10	Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows	RE
05-10	India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says	RE

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows	05-10	RE
India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says	05-10	RE
Health Care Climbs as Obesity-Drug Optimism Returns - Health Care Roundup	05-09	DJ
News Highlights : Top Company News of the Day - Thursday at 1 PM ET	05-09	DJ
Top Midday Stories: Brookfield Q1 Revenue Down; Activist Investor Gets 3 Nominees Elected to Norfolk Southern Board; Nippon Steel Raising $1.61 Billion Ahead of Planned US Steel Acquisition	05-09	MT
Novo Nordisk Partners With Metaphore Biotechnologies on New Obesity Drugs	05-09	DJ
Novo Nordisk May Pay Up to $600 Million in R&D Deal With Metaphore Biotechnologies, Flagship Pioneering	05-09	MT
Novo Nordisk Enters Research Partnership for New Weight Loss Drugs	05-09	MT
Novo Nordisk May Pay Up to $600 Million in New Obesity R&D Deal	05-09	MT
Novo Nordisk May Pay Up to $600 Million in New R&D Deal	05-09	MT
Novo Nordisk Enters Research Partnership for New Weight Loss Drugs	05-09	MT
Flagship Pioneering and Metaphore Biotechnologies Announces Research Collaboration with Novo Nordisk to Develop Next-Generation Therapeutics for Obesity Management	05-09	CI
Mickey Mouse on Wall Street	05-08
Fresenius Medical beats earnings expectations, keeps outlook; shares sink	05-08	RE
Moody’s Revises Novo Nordisk Outlook, Affirms Ratings on Robust Earnings Growth	05-07	MT
Novo Nordisk Buys DKK5.4 Billion of Shares From Novo Holdings Under Buyback	05-07	MT
Global health heavyweights team up for climate, disease funding	05-06	RE
Novo Nordisk A/S (CPSE:NOVO B) cancelled the acquisition of an unknown stake in Healthium Medtech Limited from Apax Partners LLP.	05-05	CI
News Highlights : Top Company News of the Day - Friday at 5 PM ET	05-03	DJ
News Highlights : Top Company News of the Day - Friday at 7 PM ET	05-03	DJ